Takashi Onda
Papers
2
Total Citations
22
H-Index
2
About
Dr. Takashi Onda is a leading figure in gynecologic oncology, with a focused research agenda dedicated to the safe minimization of surgical intervention for early-stage cervical cancer. Recognizing that the average age of diagnosis for cervical precancer and invasive cancer is decreasing, Dr. Onda’s work directly addresses the critical need for less invasive treatments that preserve quality of life without compromising oncologic outcomes. His seminal 2015 review, which has garnered 17 citations, systematically argues for the benefits of minimizing curative surgery, establishing a foundational rationale for subsequent clinical trials. This work culminated in his leadership of the landmark Japan Clinical Oncology Group study, JCOG1101. This pivotal confirmatory trial, published in 2023, rigorously evaluated a modified radical hysterectomy for patients with FIGO stage IB1 cervical cancer with tumors ≤2 cm. By challenging the highly invasive standard of Piver class III hysterectomy, Dr. Onda’s research is directly shaping a new, less morbid standard of care, demonstrating a profound impact on surgical practice and patient well-being.
Research Focus
Key Achievements
Top Papers
- 1
- 2